ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 61 - 80 of 246 results
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Exploring the interaction of polystyrene nanoplastics and blood plasma proteins.
The process by which plastic degrades in the ocean facilitates its entry into the natural carbon cycle efficiently as carbon dioxide.
Applications are now being accepted for the Industry foundations Scholarship.
ANSTO has provided supporting experimental evidence of a highly unusual quantum state, a quantum spin liquid (QSL), in a two-dimensional material.
ANSTO commenced an aerosol sampling program thirty years ago this week to characterise these pollutants and ultimately, identify their sources, which has taken it to the forefront of environmental monitoring of this type in Australia and the region.
ANSTO launches new area of space research in collaboration with the National Centre for Space Studies and the National Institute of Health and Medical research in France.
The nature of Metal-Oxide-Semiconductor Field Effect Transistors (MOSFETs) present a fascinating paradox in space exploration. Their strength in radiation detection becomes their weakness in space operations, exposing an Achilles' heel for NASA. Yet, these same devices monitor radiation doses received by humans on earth and in space.
You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG).
ANSTO undertakes a rigorous environmental monitoring program and shares expertise nationally and internationally.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.
The Infrared Microspectroscopy beamline combines the high brilliance and collimation of the synchrotron beam through a Bruker V80v Fourier Transform Infrared (FTIR) spectrometer and into a Hyperion 3000 IR microscope to reach high signal-to-noise ratios at diffraction limited spatial resolutions between 3-8 μm.
Soft x-rays are generally understood to be x-rays in the energy range 100-3,000 eV. They have insufficient energy to penetrate the beryllium window of a hard x-ray beamline but have energies higher than that of extreme ultraviolet light.
State- of-the-art microdosimeters used in research
ANSTO has the capability to analyse heavy isotopes such as 129I, platinum group elements, 236U and Pu isotopes.